VacV Biotech

Biotechnology, Health Care, Life Science, Medical
Founded in 1/1/22
London, England, United Kingdom
http://www.vacvbtx.com/
For Profit

About VacV Biotech

VacV Biotherapeutics develops an oncolytic virus platform based on the vaccinia virus. The platform genetically modifies the oncolytic virus, which improves its specificity to tumors, reduces neurotoxicity, enhances the therapeutic effect, and greatly increases the production of extracellular enveloped virus (EEV). It has higher safety and efficiency and can be administered by intravenous injection.

Company Metrics

  • Employees: 1-10
  • Monthly Visits: 333
  • Tech Stack: None active products

Financial Information

  • Estimated Revenue:
  • Total Funding: 3000000 USD
  • Last Funding: 3000000 USD (Venture - Series Unknown)
  • Funding Status:

Technology Stack

VacV Biotech actively uses None products in their tech stack.

Market Presence

Industries: Biotechnology, Health Care, Life Science, Medical

Headquarters: London, England, United Kingdom